Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer
Funder: Medical Research CouncilDuration: June 2020 - October 2021
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Dr Annabelle Lewis Senior Lecturer in Biomedical Sciences (Principal investigator)
T: +44 (0)1895 266607
E: annabelle.lewis@brunel.ac.uk |
+44 (0)1895 266607 | annabelle.lewis@brunel.ac.uk | Heinz Wolff 130 |
Outputs
O’Cathail, SM., Wu, C-H., Thomas, R., Hawkins, MA., Maughan, TS. and Lewis, A. (2021) 'Nrf2 mediates therapeutic resistance to chemoradiation in colorectal cancer through a metabolic switch'. Antioxidants, 10 (9). pp. 1 - 14. ISSN: 2076-3921 Open Access Link
Lewis, A., Russell, H., Kedzierska, K., Buchanan, D., Thomas, R., Tham, E., et al. (2020) 'The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability'. Clinical Epigenetics, 12 (1). pp. 1 - 9. ISSN: 1868-7075 Open Access Link